Novo Nordisk’s Wegovy gets MHRA nod for use to lower heart risks

Read more

Recent study shows BioCity’s potential to differentiate in kidney disease space

Read more

Union Budget 2024-25 reflects a forward-looking and inclusive approach

Read more

The budget allocation for R&D will be beneficial for the clinical trial industry

Read more

Decoding Budget 2024-25: A lacklustre budget for pharma

Read more

Gland Pharma receives tentative USFDA approval for Latanoprostene Bunod Ophthalmic Solution

Read more

ZIM Laboratories gains approval to market Azithromycin for Oral Suspension 200 mg/5ml (40 mg/ml) in Portugal

Read more

Zydus receives final US FDA nod for Valsartan Tablets

Read more

SynaptixBio collaborates with Evotec to boost search for rare disease therapies

Read more

IPC waves off TABST in Indian Pharmacopoeia

Read more